Central Pennsylvania Transplant Foundation

Harrisburg, Pennsylvania 17104

0 studies enrolling now · 2 studies all time

What they study most

Antibody-mediated Rejection, Delayed Function of Renal Transplant

Studies at this site

• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Efficacy and Safety of SANGUINATE™ for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant — Completed